Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, Inc.
Federal Register, Volume 83 Issue 25 (Tuesday, February 6, 2018)
Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)
Notices
Pages 5274-5275
From the Federal Register Online via the Government Publishing Office www.gpo.gov
FR Doc No: 2018-02343
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Docket No. DEA-392
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written
Page 5275
comments on or objections to the issuance of the proposed registration on or before April 9, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July 21, 2017, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Chattanooga, Tennessee 37409 applied to be registered as a bulk manufacturer for the basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
4-Methoxyamphetamine................... 7411 I
Dihydromorphine........................ 9145 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Lisdexamfetamine....................... 1205 II
Methylphenidate........................ 1724 II
Pentobarbital.......................... 2270 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Meperidine............................. 9230 II
Meperidine intermediate-A.............. 9232 II
Meperidine intermediate-B.............. 9233 II
Meperidine intermediate-C.............. 9234 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Opium tincture......................... 9630 II
Opium, powdered........................ 9639 II
Opium, granulated...................... 9640 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Alfentanil............................. 9737 II
Remifentanil........................... 9739 II
Sufentanil............................. 9740 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers.
In reference to drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.
Dated: January 30, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
FR Doc. 2018-02343 Filed 2-5-18; 8:45 am
BILLING CODE 4410-09-P
